ACHC Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, NEC · Nasdaq · SEC CIK 1520697 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.5%
TTM net income YoY-1,150.7%
TTM EPS YoY-1,154.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-33.1%
FCF margin-0.7%
EBITDA margin—
Returns
ROE-43.9%
ROA-18.9%
ROIC (approx.)—
Asset turnover0.57x
Leverage & solvency
Liabilities / assets59.5%
Debt / equity1.16x
Current ratio1.60x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.21x
Accruals ratio-22.8%
Payout ratio—
Capex / revenue7.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $3.31B | $3.15B |
| SG&A expense | $177.60M | $156.80M |
| Pretax income | -$1.07B | $341.88M |
| Income tax | $25.98M | $77.39M |
| Net income | -$1.10B | $255.61M |
| EPS (basic) | -12.16 | 2.79 |
| EPS (diluted) | -12.16 | 2.78 |
| Weighted avg. shares (diluted) | 90.70M | 92.06M |
| Banking | ||
| Net interest income | -$138.86M | -$116.37M |
| Balance sheet | ||
| Cash & equivalents | $133.24M | $76.31M |
| Receivables | $440.60M | $365.34M |
| Inventory | $5.69M | $5.65M |
| Current assets | $814.14M | $577.49M |
| PP&E, net | $3.11B | $2.85B |
| Goodwill | $1.30B | $2.26B |
| Intangibles | $96.67M | $70.00M |
| Total assets | $5.53B | $5.96B |
| Current liabilities | $525.19M | $577.92M |
| Short-term debt | $28.44M | $76.82M |
| Long-term debt | $2.47B | $1.88B |
| Total debt | $2.50B | $1.96B |
| Total liabilities | $3.39B | $2.77B |
| Shareholders' equity | $1.95B | $3.07B |
| Net debt | $2.37B | $1.88B |
| Shares outstanding | 90.45M | 91.78M |
| Cash flow statement | ||
| Operating cash flow | $131.90M | $129.69M |
| Capital expenditure | $571.81M | $690.38M |
| Free cash flow | -$439.91M | -$560.69M |
| Investing cash flow | -$556.21M | -$736.48M |
| Financing cash flow | $481.25M | $583.02M |
| Depreciation & amortization | $189.25M | $149.59M |
| Stock-based compensation | $31.71M | $37.11M |
| Share buybacks | $50.03M | — |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.